For doctors and healthcare professionals
Physician Portal
Practical MASLD and MASH learning, organised by topic and by your role.
Featured
Next live lecture
Upcoming talks and webinars, with times in Riyadh time and GMT.
On-demand library
Recorded talks for clinicians and patient-education videos in Arabic.
MASLD essentials for primary care
- Names and definitions
- Finding people at risk
- FIB-4 and elastography
- Lifestyle counselling that works
- Drugs and referral
Teaching modules
Chapter-length modules with learning objectives, graded guideline recommendations, figures, a clinical case, self-test questions and full references. Free, no login, not accredited for CME.
- Module 1. Assessing liver fibrosis in MASLDAbout 25 minutes. Prognosis, FIB-4 and NFS, elastography and ELF, the pathway, a case and 5 questions.
- Module 2. Choosing drug treatment for MASHAbout 28 minutes. Who qualifies, resmetirom and semaglutide in practice, monitoring and stopping rules, other drugs by guideline.
- Module 3. The lifestyle prescriptionAbout 25 minutes. Weight-loss targets, diet quality, activity, alcohol, obesity medicines, surgery and Ramadan.
- Module 4. MASLD in the diabetes clinicAbout 28 minutes. Testing every patient with type 2 diabetes, choosing glucose-lowering drugs, heart and kidney risk, clinic workflow.
- Module 5. Caring for MASLD cirrhosisAbout 28 minutes. Baveno VII, portal hypertension, liver cancer surveillance, metabolic care, surgery and transplant.
Topic hubs
Each hub gathers everything on one topic: guidance, tools, patient material and talks.
MASLD Hub
Obesity–Liver Hub
Start by your role
| Your role | What matters most | Start here |
|---|---|---|
| GP / family medicine | Spotting risk, FIB-4, when to refer | FIB-4 · Referral pathway |
| Internist / endocrinologist | Screening in diabetes and obesity; drugs that help both | MASLD Hub · Drugs |
| Dietitian | Weight-loss targets; Mediterranean-style plans adapted to Gulf food | Lifestyle |
| Nurse | Patient education, FibroScan basics, follow-up | Patient journey |
| Trainee / resident | The whole picture, from definitions to treatment | All hubs · Lectures |
FIB-4 calculator
For healthcare professionals. The first step of the fibrosis pathway in adults with MASLD.
These calculators are for doctors and other healthcare professionals. If you are a patient, please do not interpret your own results: share your blood test with your doctor. For a simple check made for patients, try Am I at risk?
Open the calculator hub: Agile 3+, Agile 4, FAST, FibroScan explainer, FLI, HSI, HOMA-IR and more →
FIB-4 = (age × AST) ÷ (platelets × √ALT). Below 1.3 (2.0 if aged 65 or over) makes advanced fibrosis unlikely; 2.67 or above makes it likely. Not validated under age 35. Based on the EASL–EASD–EASO 2024 and AASLD 2023 guidance. Read the method, intended users and limits.
NAFLD fibrosis score (NFS) calculator
For healthcare professionals. An alternative first-line score to FIB-4, useful when albumin and BMI are at hand.
Below −1.455 (0.12 if aged 65 or over) makes advanced fibrosis unlikely; above 0.676 makes it likely. Obesity and diabetes push the score up. Read the method and limits.
Why no APRI calculator? APRI was developed for hepatitis C and is less accurate in MASLD; current guidelines prefer FIB-4 or NFS.
Global research and collaboration
International work on MASLD that clinicians in our region can follow or take part in. The Academy is independent and not affiliated with these groups.
Global Liver Registry
Global NASH Council
An international registry of people living with MASLD and MASH. The Council's page explains its aims and how centres can take part.
Global consensus recommendations
Global NASH Council · Gastroenterology, 2025
One set of recommendations built from 61 guidelines and guidance documents (2018 to January 2025) through four Delphi rounds. Our teaching modules compare it with EASL, AASLD and the Saudi consensus.
Educational materials for clinicians
Global NASH Council
The Council's educational materials for clinicians caring for people with MASLD.
Publication Radar
Metabolic Liver Academy
New MASLD and MASH papers from PubMed every day, with a separate tab for research from the Middle East and North Africa.
Running a MASLD study, registry site or trial in the region? Email mdesoky15@gmail.com to have it listed here.